356 results about "Molecular probe" patented technology

The invention relates to a radionuclide-labeled glucose derivative molecular probe and application thereof, and belongs to the technical field of nuclear medicine. According to the present invention, propargyl glycine is used to synthesize an amino acid skeleton, and the amino acid skeleton reacts with glucose azide to prepare a series of radionuclide-labeled glucose derivative molecular probes, such as [68Ga] Ga-NOTA-SDG, [68Ga] Ga-NOTA-DDG, [68Ga] Ga-NOTA-TDG, [68Ga] Ga-DOTA-SDG, [68Ga] Ga-DOTA-DDG and the like; the glucose derivative molecular probe labeled by the series of radionuclides has the advantages of being simple and rapid in labeling, high in radiolabeling yield and good in stability, can accurately position tumors, has good tumor uptake and lower non-target tissue uptake, and has great application prospects in preparation of broad-spectrum tumor imaging agents.

The invention discloses a radionuclide labeled molecular probe for detecting collagen structure denaturation and a preparation method and application thereof, and relates to the technical field of biology. The structural general formula of the radionuclide labeled molecular probe disclosed by the invention is as follows: K (chelating agent-nuclide)-K-Linker-CHP, wherein K (chelating agent-nuclide) is a lysine residue labeled by a side chain amino coupling chelating agent and a radionuclide; the Linker is a connection joint; cHP is a collagen hybrid peptide with a polypeptide sequence of (GfO) n or (GPO) n. The probe has excellent definition and signal-to-noise ratio, not only can detect pancreatic ductal adenocarcinoma in a pancreatic cancer model, but also can sensitively detect precancerous lesions (such as pancreatic intraepithelial neoplasia lesions) of the pancreatic ductal adenocarcinoma and pulmonary fibrosis lesions in a bleomycin pulmonary fibrosis model. And the kit has important significance on early detection of pancreatic duct adenocarcinoma and reflection of dynamic change of ECM remodeling.

The use of an SNP site combination of Litopenaeus vannamei in trait evaluation of mixed-family culture, a probe and a kit. The SNP site combination of Litopenaeus vannamei comprises 1125 SNP sites, wherein the physical positions are determined on the basis of alignment with a reference genome sequence of Litopenaeus vannamei. Also disclosed are a molecular probe for capturing the SNP site combination and a kit comprising the molecular probe. By means of using the SNP site combination for paternity identification, the present invention can achieve the mixed culture of individuals of different families in the early stage, so that the common environmental effect caused by separate family culture in the early stage is effectively reduced, and the accuracy of a trait evaluation result of mixed culture is improved; moreover, the genetic relationship between individuals can be accurately calculated. Compared with physical marks, the present invention avoids the phenomena of falling and dislocation of marks on individuals and human identification errors, thus obtaining accurate pedigrees.

The invention belongs to the technical field of gene detection and gene molecular breeding, and particularly relates to a meat duck whole genome molecular probe combination based on molecular phenotype screening, a 50K gene chip and application thereof. The molecular probe combination and the gene chip of the marker site combination for meat duck whole genome breeding simultaneously cover 7 representative meat duck varieties and 71 economic characters, have richer polymorphism and higher pertinence in meat duck groups, and are lower in cost and higher in speed compared with high-throughput sequencing detection; the breeding chip is designed according to the growth, feed efficiency, slaughtering, breeding, egg quality and various molecular phenotypes of the meat ducks, and compared with a high-throughput sequencing technology, the breeding chip is higher in seed selection accuracy, has higher breeding value, can be widely applied to breeding genotype detection of the meat ducks, and can be used for detecting the breeding genotypes of the meat ducks. And the method has creative significance in the aspect of meat duck genome selective breeding.

The invention discloses a molecular marker combination for analyzing goat varieties and application, relates to the technical field of biology, and provides 13947 molecular markers capable of analyzing goats, and the physical position information of the molecular markers is determined based on genome sequence comparison of a goat reference genome ARS1.2. A molecular probe combination, a gene chip and a kit prepared from 13947 SNP molecular markers can be used for carrying out genetic evaluation on goat individuals, carrying out individual selection on goat varieties which are difficult to determine in the early stage, shortening the generation interval and accelerating the breeding process, so that a large amount of breeding cost is saved.

The invention discloses a tumor targeting reagent and application thereof in tumor diagnosis. The targeting reagent has strong affinity to tumors, strong specificity and no biotoxicity, is relatively stable in vivo, and can be used as a molecular probe to be applied to molecular imaging and / or treatment of various integrin alpha6 high-expression tumors; the targeting reagent provided by the invention comprises the tumor targeting peptide RWYDeA, and further comprises a radionuclide chelating agent, other connecting structures and a hydroxyl substitution structure, and the structure is beneficial to improving the tumor targeting property of the targeting reagent, prolonging the tumor binding time and achieving a better tumor diagnosis effect; the method can be used for preparing products for diagnosing / treating diseases related to high expression of integrin alpha6.

The application relates to a DNAzyme-based gene chip biosensor and application thereof, and belongs to the technical field of electrochemical sensors. In order to solve the technical problems of low specificity and accuracy, long processing time and high cost in the single nucleotide polymorphism detection method in the prior art, a DNAzyme-based gene chip biosensor is provided, which comprises a DNAzyme molecular probe SNP recognition system and a solid-liquid phase mixed catalytic network system. The application provides a proteinase-free and space-oriented biosensing strategy, utilizes a molecular switch based on a DNAzyme probe to realize accurate SNP recognition, utilizes a space steric hindrance parallel amplification system to enhance signal amplification and simultaneously inhibit background noise, so that the detection performance is remarkably improved; and the gene chip biosensor can be applied to genotyping and trait selection in crop improvement and other applications.

The invention relates to an oxidase response type molecular probe as well as a preparation method and application thereof, and belongs to the technical field of medical imaging. Aiming at the problem that the inflammation activity is difficult to accurately evaluate in the prior art, the invention provides a molecular imaging probe capable of responding to the activity of in-vivo myeloperoxidase (MPO), and the molecular imaging probe can be used for real-time and non-invasive imaging monitoring of the activity of the in-vivo MPO, so that the activity of the inflammatory reaction of a focus is accurately evaluated. The invention provides a chelating agent with structural characteristics of a chelating unit and an enzyme response unit, and is characterized in that the enzyme response molecular probe is constructed by taking rigid framework cyclohexanediamine (CDTA) as a transition metal chelating unit and taking electron-rich functional groups (such as phenol, catechol or 5-hydroxytryptamine) as the enzyme response unit. The probe is chelated with paramagnetic metal (such as Mn < 2 + >) for magnetic resonance imaging (MRI) or radioactive metal (such as 68Ga) for positron emission tomography (PET), so that specific response to MPO activity is realized. The dynamic stability of the probe is remarkably improved; after the MPO is responded, the relaxation efficiency is improved by 2-3 times, and the sensitivity is optimized; the cytotoxicity is low; in an acute pancreatitis model, the MRI contrast noise ratio (delta CNR) reaches 77.39 + / -7.04 and is 4.2 times that of a control group, the PET uptake rate is remarkably improved, bimodal imaging is supported, and accurate positioning and quantitative evaluation of the inflammation activity are achieved.

The invention relates to a specific PET molecular probe of a targeted KRASG12D mutant as well as a preparation method and application of the specific PET molecular probe. Pyridopyrimidine compounds and R5 are subjected to cooling reaction under the action of N, N-diisopropylethylamine to generate a compound 2; the compound 2 and (2-fluorotetrahydro-1H-pyrrolizine-7A (5H)-yl) methanol are subjected to a heating reaction under the action of N, N-diisopropylethylamine, and a compound 3 is generated; carrying out heating reaction on the compound 3 and biphenyl boronic acid pinacol ester under the action of N, N-diisopropylethylamine and tetrakis (triphenylphosphine) palladium to generate a compound 4; carrying out heating reaction on the compound 4 and 1, 2-bis (tolyloxy) alkane under the action of potassium carbonate to generate a compound 5; the compound 5, radioisotope < 18 > F and an anion complexing agent are subjected to a heating reaction under the action of potassium carbonate to generate the trisubstituted pyridopyrimidine < 18 > F labeled PET molecular probe. Compared with the prior art, the kit has a positioning diagnosis effect on KRASG12D mutant tumors, and image typing of mutant and non-mutant tumors and pathological evaluation after tumor treatment are realized at the same time.

The invention relates to a molecular probe for targeting a prostate specific membrane antigen and application, and belongs to the technical field of nuclear medicine. The invention provides a molecular probe for targeting a prostate specific membrane antigen, and the molecular probe successfully obtains a PSMA targeting molecular probe by introducing iodobenzene butyric acid and a PEG4 group on the basis of a PSMA-617 molecular structure on the basis of a double-ligand covalent coupling technology. The molecular probe has the advantages that the residence time of the molecular probe in a tumor area is obviously prolonged, the treatment effect is improved, the requirement for radioactive dose is reduced, and radiation damage to surrounding normal tissues is reduced; the specificity is excellent, a tumor area with high PSMA expression can be accurately targeted, and tumors with different PSMA expression levels can be effectively distinguished; the speed of reaching a target tumor is high, and an ideal imaging effect can be realized only in 20 minutes. In conclusion, the molecular probe has great advantages in diagnosis and treatment of PSMA high-expression tumors, and has high specificity and high efficiency.

The invention discloses a nano antibody targeting GPRC5D as well as a preparation method and application thereof, and belongs to the technical field of biological medicines. The nano antibody is generated by mixed immunization of a GPRC5D polypeptide antigen with a sequence shown as SEQ ID NO: 1 and a GPRC5D protein antigen with a sequence shown as SEQ ID NO: 2. The preparation method comprises the following steps: mixing the GPRC5D polypeptide antigen and the GPRC5D protein antigen to immunize alpaca, sampling blood, constructing an antibody library, screening a phage display antibody library, expressing protein, and selecting the nano antibody with the highest affinity. The invention further provides a radionuclide labeled molecular probe, the nano antibody is small in molecular weight and can recognize a large number of epitopes, and the molecular probe prepared from the nano antibody can obtain high-quality images, is used for preparing products for developing multiple myeloma or detecting GPRC5D expression level and has wide application prospects.

The invention discloses a bifunctional fluorescent molecular probe, a preparation method thereof and application of the bifunctional fluorescent molecular probe in polarity detection of ONOO <-> and lipid droplets, and belongs to the technical field of polarity detection of ONOO <-> and lipid droplets. The problems that a fluorescent probe is only limited to detection of a single analyte, and targeted monitoring of lipid droplets in cells and simultaneous detection of endogenous ONOO <-> in the cells cannot be achieved are solved. According to the invention, a dual-response fluorescent molecular probe PTQ based on a triphenylamine group is prepared, and the PTQ shows dual response to a polar environment and dynamic change of ONOO <->. Test results show that the fluorescent probe shows high sensitivity (1.92 nM), stable fluorescence signals and high quantum yield (57.76%) in a low-polarity medium, also has excellent ONOO <-> selectivity, low detection limit (4.97 nM), low toxicity and excellent biological imaging ability, and realizes targeted monitoring of lipid droplets and detection of endogenous ONOO <-> in cells.

The invention provides an image processing method and device for early detection of Alzheimer's disease, a storage medium and equipment. The image processing method comprises the following steps: an image acquisition stage: acquiring a brain 1H magnetic resonance anatomical image of a tester before taking a labeled probe and acquiring a brain 2H magnetic resonance metabolism image set of the tester within a preset time period after taking the labeled probe; an image processing stage: performing magnetic resonance signal quantitative estimation according to the brain 2H magnetic resonance metabolism image set to obtain a metabolic flux characteristic quantitative image set, and registering the metabolic flux characteristic quantitative image set to the brain 1H magnetic resonance anatomical image to obtain a training sample; and a model training stage: training a preset diagnosis model by the training sample, wherein the diagnosis model is a feature pyramid deep learning model based on Context Transform Block. Metabolic flux characteristic changes of AD in the early stage can be captured, dynamic injection and multi-period continuous scanning of the molecular probe are marked, and long-term tracking is achieved.

The invention belongs to the technical field of fluorescent probes and supramolecules, and particularly relates to an organic small molecule fluorescent probe for lithium ion detection as well as a synthesis method and application of the organic small molecule fluorescent probe. Aiming at the problems that an existing fluorescent probe for identifying Li < + > is easily influenced by pH and interfered by coexisting metal ions, and is poor in water solubility, low in sensitivity, poor in selectivity and the like, the crown ether fluorescent molecular probe for detecting the lithium ions is 4-aza-12-crown-4-ether-7-nitrobenzofuran; the compound is prepared from 4-chloro-7-nitrobenzofuran and aza 12-crown-4-ether in a substitution manner. The fluorescent probe has the advantages that 1) the structure is simple, the preparation is easy, and excitation and emission wavelengths are in a visible light region; 2) good water solubility is achieved; 3) the material has good selectivity on lithium ions; 4) the method has the advantages of high sensitivity, quick response and the like in lithium ion detection, and can be used for in-situ-real-time detection of lithium ions; and (5) the cell toxicity is low, and the biocompatibility is good.

The invention relates to a carbonic anhydrase IX targeted molecular probe and application thereof, and belongs to the technical field of nuclear medicine. The invention provides carbonic anhydrase IX targeted molecular probes 18F-SAZ and 18F-DAZ, and the two molecular probes have the following advantages: firstly, the specificity is strong, and the molecular probes can be selectively taken in a CAIX positive tumor part so as to better distinguish carbonic anhydrase IX negative and positive tumors; secondly, the compound can quickly reach a carbonic anhydrase IX positive tumor, a better imaging effect can be obtained within 30 minutes, and the compound has better retention property; and thirdly, the in-vivo metabolism is rapid, the biological half-life period is shorter, the in-vivo clearing time is obviously shorter than that of an antibody molecular probe, and the safety is higher. In conclusion, the two molecular probes can dynamically monitor the change of the level of carbonic anhydrase IX in tumor cells in real time through PET imaging, and have great application prospects in diagnosis of positive tumors of carbonic anhydrase IX.

The invention discloses a tumor treatment molecule with a curative effect self-amplification function. Belongs to the technical field of biotechnology and new medicine, and comprises a peptide sequence Ac-Asp-Glu-Val-Asp-Cys (StBu)-Lys combined to a CBT part and a paclitaxel chemotherapy molecule connected to a lysine side chain. After the probe enters a tumor cell, the probe is specifically recognized by reducing glutathione highly expressed in the tumor cell, and an Ac-DEVDCK (PTX)-CBT structure is generated; then, a weak cell apoptosis phenomenon is initiated through a molecular grafted paclitaxel structure; the Ac-DEVD fragment is used as a high-specificity polypeptide substrate of cysteine-aspartic acid specific protease 3 which is necessary in a cell apoptosis pathway, and can be specifically cut by the cysteine-aspartic acid specific protease 3, so that the Ac-DEVDCK (PTX)-CBT is converted into CK (PTX)-CBT; then, CK (PTX)-CBT molecules are subjected to a CBT-Cys click reaction to form a cyclic dimer, and the cyclic dimer is self-assembled to form particles. According to the method, the affinity of the paclitaxel to the tubulin in the cytoskeleton is utilized, so that the tubulin in the cell is aggregated, the self-amplification effect of the curative effect of the cell is realized, and the cell is triggered to generate a pan-apoptosis effect.

The invention discloses a molecular marker combination for analyzing varieties of milk goats and application of the molecular marker combination, relates to the technical field of biology, and provides 2014 molecular markers capable of analyzing the features of the varieties of the milk goats, and the physical position information of the molecular markers is compared and determined based on the genome sequence of a goat reference genome ARS1. A molecular probe combination, a gene chip and a kit prepared from the 2014 SNP molecular markers can be used for carrying out genetic evaluation on goat individuals, individual selection is carried out on milk goat varieties which are difficult to measure in the early stage, the generation interval is shortened, the breeding process is accelerated, and therefore a large amount of breeding cost is saved.

The invention belongs to the technical field of biological medicine detection, and particularly relates to an SERS / fluorescent bimodal composite probe, a preparation method and application thereof and a chiral glucose detection method, the composite probe is a gold nanorod modified by a tetraphenylethylene nuclear derivative, and the tetraphenylethylene nuclear derivative is a TPE nuclear molecular probe with AIE attributes; the tetraphenyl ethylene core derivative is prepared by reacting tetrabromo tetraphenyl ethylene with bis (pinacolato) diboron, oxidizing, and reacting with p-mercaptophenylboronic acid. Compared with the prior art, the method has the advantages that the limitations of long time consumption, insufficient sensitivity or specificity deficiency of the traditional chiral molecule identification method in the prior art are solved; and SERS (Surface Enhanced Raman Scattering) and fluorescence analysis are lack of methods and materials suitable for chiral molecule identification. According to the scheme, the composite nanoprobe can form a sandwich structure with molecules of an object to be detected, and rapid detection of chiral glucose is realized according to SERS intensity, fluorescence intensity and color change of the composite nanoprobe.

The invention relates to the technical field of molecular probes, and particularly discloses a molecular probe of a targeted tyrosine kinase receptor as well as a preparation method and application of the molecular probe, the molecular probe comprises radioisotope, targeted polypeptide and a chelating group, the targeted polypeptide specifically targets the tyrosine kinase receptor, the chelating group is connected with the targeted polypeptide to form a targeted precursor, and the chelating group is connected with the targeted polypeptide to form the targeted precursor. The radioactive isotope labeled precursor forms a molecular probe, and the sequence of the targeted polypeptide is shown as any one of SEQ ID No.1-8. The targeting polypeptide has good targeting property on a tyrosine kinase receptor coded by an RET gene, can realize specific high uptake in a cell line of NEPC, has relatively good biological safety, can realize accurate imaging aiming at NEPC, and clearly and durably visualizes NEPC tumors in PET imaging; meanwhile, the molecular probe can effectively delay the growth capacity of NEPC, can provide a new treatment choice for NEPC patients, and has good clinical transformation potential.

This invention discloses a near-infrared two-photon dual-mode linked response NTR&Cys fluorescent probe, its preparation method, and its application, belonging to the field of medical detection technology. The structural formula of the near-infrared two-photon dual-mode linked response NTR&Cys fluorescent probe is as follows: The near-infrared two-photon dual-mode linked response NTR&Cys fluorescent probe of this invention possesses a hypoxia dual-mode visual monitoring molecular framework, enabling dual-mode determination of hypoxia microenvironments. It improves the stability of the cyanine near-infrared framework and achieves highly stable and specific detection of nitroreductase under hypoxia. Under hypoxia conditions, the product reacts with NTR, and the single-photon excited near-infrared fluorescence is quenched and then illuminated. Simultaneously, under hypoxia, the probe reacts with Cys to generate a two-photon excited fluorescence signal, effectively avoiding the probe consumption problem of dual-response systems and ensuring the non-interference of fluorescence excitation and emission (dual-mode), thus truly achieving accurate locking of hypoxia microenvironments.

The invention discloses a near-infrared two-region aggregation-induced emission probe, nanoparticles, a preparation method and application, and relates to the technical field of fluorescent molecular probes. The structural formula of the near-infrared two-region aggregation-induced emission probe is shown in the specification, wherein X1, X2 and Y are respectively and independently selected from one of O, S, Se and Te; r1, R2 and R3 are respectively and independently selected from one of H, F, cyano, trifluoromethyl and saturated alkane. The probe provided by the invention has relatively high luminous efficiency, photo-thermal efficiency and active oxygen generation capability in an aggregation state, and can realize fluorescence, photo-acoustic and photo-thermal multi-mode imaging and photo-thermal / photodynamic synergistic treatment.

The invention relates to the technical field of genetic breeding, in particular to an application of an SNP (Single Nucleotide Polymorphism) site combination, a molecular probe group for detecting the SNP site combination or a liquid phase chip containing the molecular probe group in duck breeding. The invention discloses an SNP locus combination, a molecular probe group for detecting the SNP locus combination and a liquid phase chip containing the molecular probe group by screening common SNP loci and specific SNP loci of three duck species of Jinding duck, Shaoxing duck and Fujian mountain sheldrake, and the SNP locus combination, the molecular probe group and the liquid phase chip can be used for duck species screening, breeding or identification. The invention further provides a method for identifying the Jinding duck, the Fujian mountain sheldrake or the Shaoxing duck population, and an important detection method and means are provided for establishing a rapid and automatically-operated experimental duck genetic quality detection technical system.

This invention discloses an AfBPP-based active molecular probe for thiostreptin, its preparation, and its application, belonging to the field of chemical biology. This invention introduces a bifunctional tag integrating a photocrosslinking group (bisacrididine) and a bioorthogonal reactive group (alkynyl group) into the structure of thiostreptin. While retaining the original biological activity of the parent compound, it endows the probe with highly efficient probe function, solving the technical problem of target loss during washing and purification of traditional non-covalent probes. After target labeling, the probe can specifically connect to reporter groups such as fluorescein or biotin through click-chemical reactions, achieving efficient enrichment of drug targets. Combined with mass spectrometry analysis, it enables global identification of potential targets in cells or complex biological samples at the omics level, such as chemical proteomics, providing a powerful molecular tool for in-depth revelation of the potential targets and pharmacological mechanisms of thiostreptin.

The present invention provides a compound with which a molecular probe capable of distinguishing NSCs from CSCs can be produced, and a method for detecting cancer stem cells using the compound. The present invention relates to a compound having a formyl group, a substrate moiety, a quenching moiety, and a luminescent moiety that is non-luminous due to the quenching moiety, wherein the luminescent moiety may be rendered luminous by detaching the substrate moiety by a substrate-degrading enzyme and also converting the formyl group to a carboxy group by an aldehyde dehydrogenase to allow the quenching moiety to dissociate.

The invention relates to the technical field of tumor molecular imaging, nuclear medicine diagnosis and targeted therapy, and discloses a Trop2-targeted polypeptide, a Trop2-targeted molecular probe and application of the Trop2-targeted polypeptide and the Trop2-targeted molecular probe. The polypeptide can be coupled with different imaging elements to construct molecular probes or radiopharmaceuticals for tumor targeted imaging, so that noninvasive visual detection on the Trop2 expression level in tumor tissues is realized. The probe can specifically recognize Trop2 positive solid tumors, and a new technical means is provided for noninvasive diagnosis and dynamic monitoring of various Trop2 high-expression tumors such as pancreatic cancer, lung cancer, breast cancer and thyroid cancer. The probe disclosed by the invention has the advantages of simple preparation process, low cost, high specificity and stability, short imaging period, low radiation dosage, easiness in clinical transformation and the like, and has a wide application prospect in precise diagnosis and individualized treatment of tumors.

The present invention discloses a quantitative evaluation method of in vivo molecular probes based on xenon / phosphorus multi-nuclear magnetic resonance, which obtains the corresponding curve between the pH value of the molecular probe saturated solution and the molecular probe saturation concentration and 129 Sensitivity distribution diagram of the Xe transceiver integrated coil; obtain the hydrogen proton magnetic resonance structure image of the test area of ​​the test object; obtain the 3D 31 P chemical shift imaging data, to obtain molecular probe 129 Xe magnetic resonance signal distribution image; obtain pH value distribution image of the detection object to be tested area; obtain molecular probe concentration distribution image in the detection object to be tested area; calculate the molecular probe position coordinates of the detection object to be tested area and the molecular probe concentration distribution image; calculate the molecular probe position coordinates of the detection object to be tested area and the molecular probe concentration distribution image; calculate the molecular probe position coordinates of the detection object to be tested area and the molecular probe concentration distribution image; calculate the molecular probe concentration distribution image ... 129 The present invention can realize the concentration of molecular probes and the molecular probes that are difficult to detect in vivo without damage. 129 Quantitative measurement of parameters such as Xe apparent binding rate.

The present invention discloses a molecular marker combination and application for analyzing sheep breeds, relating to the field of biotechnology. The present invention provides 10,082 molecular markers capable of analyzing sheep, wherein the physical location information of the molecular markers is determined based on genome sequence alignment of the sheep reference genome Oar_rambouillet_v1.0. A molecular probe combination, a gene chip, and a kit prepared using the 10,082 SNP molecular markers can be used to perform genetic assessment on individual sheep, perform individual selection on sheep breeds that were difficult to measure in the early stages, shorten the generation interval, accelerate the breeding process, and thus save a large amount of breeding costs.

The application discloses a specific nucleic acid aptamer for a heterogeneous core ribonucleoprotein hnRNPA2B1 and application, and belongs to the technical field of nucleic acid aptamer. The hnRNPA2B1 aptamer is a small single-stranded DNA screened from a designed oligonucleotide library through an in-vitro exponential enrichment ligand system evolution (SELEX), is composed of 80 nucleotides, and has high affinity to the target. The hnRNPA2B1 aptamer can be applied in a detection method or a detection product of the hnRNPA2B1 protein, and a targeted regulation drug or a biological preparation, and can be specifically made into a molecular probe, used as a detection reagent, used as a targeted preparation and the like for diagnosis and treatment of diseases related to the hnRNPA2B1 protein. The hnRNPA2B1 aptamer has strong affinity and specificity, has the advantages of low production cost, stability, convenient synthesis and easy modification compared with an antibody, and is a potential substitute for the antibody in disease diagnosis and treatment.

The invention provides a molecular probe targeting EDB-FN as well as a preparation method and application of the molecular probe. The structural formula of the molecular probe targeting EDB-FN is shown in the specification, according to the molecular probe targeting EDB-FN, the probe is based on a cyclic peptide probe with Lys-Glu side chain lactam bridge conformation fixed, the connection mode of a DOTA chelating agent is optimized, and the clinical transformation bottlenecks that an existing probe is poor in stability, low in affinity, insufficient in targeting specificity, poor in diagnosis and treatment integration compatibility and the like are solved. The probe can be used for early diagnosis and molecular imaging research of tumors, and provides a reliable basis for tumor malignancy degree evaluation and treatment effect monitoring.

This application discloses a linker and its preparation method. The linker includes pharmacophore P, pharmacophore Q, and deoxynucleotides and / or deoxynucleotide derivatives connecting pharmacophore P and pharmacophore Q. Pharmacophore P is obtained by removing the protecting group from group B, and pharmacophore Q is obtained by removing the protecting group from group X. Group B is obtained by chemically modifying the benzylquinolone carboxylic acid pharmacophore, and group X is obtained by chemically modifying the zenomeprazole pharmacophore. The linker is prepared by linking group B and group X with deoxynucleotides and / or deoxynucleotide derivatives to form the linker, including solid-phase synthesis technology. The method of this application can automatically synthesize molecular probes or bivalent drugs containing two pharmacophores, thereby replacing the traditional stepwise linking method, enabling efficient construction of screening libraries, and allowing control of the spatial distance and spatial orientation of the pharmacophores by adjusting the number and base arrangement of deoxynucleotides.